THE EFFECT OF HYPERBARIC OXYGEN THERAPY IN TREATING FOR IRRADIATED HEAD AND NECK CANCER PATIENTS: A SYSTEMATIC REVIEW
Main Article Content
Abstract
Objectives: To summarize the effectiveness of hyperbaric oxygen therapy in the treatment of patients
who underwent radiation therapy for head and neck cancer from 1992 to 2022.
Subjects and methods: This systematic review uses the open data sources Pubmed, Google Scholar
to search for articles and full-text researches written in English in accordance with the selection
criteria.
Results: The number of articles selected and included in the systematic review was 21. The results
show that hyperbaric oxygen therapy is effective in reducing xerostomia, however, its effectiveness
in reducing risk/accelerating healing process of osteoradionecrosis and improving patients’ quality
of life has not been agreed.
Conclusion: More well-designed randomized controlled trials with uniform protocols are needed to
recommend the use of hyperbaric oxygen therapy for irradiated head and neck cancer patients.
Article Details
Keywords
Hyperbaric oxygen, head and neck cancer, radiation therapy, systematic review
References
statistics 2018: GLOBOCAN estimates of incidence
and mortality worldwide for 36 cancers in 185
countries, CA: A Cancer Journal for Clinicians, 2018;
68(6): 394–424.
[2] Gupta H, Hyperbaric Oxygen Therapy: Mechanism of
Action and its Application in Periodontics: A Review,
International Journal of Oral Implantology & Clinical
Research, 2018; 9(1-3): 11–16.
[3] Cankar K, Finderle Z, Jan J, The Effect of Hyperbaric
Oxygenation on Postradiation Xerostomia and Saliva
in Patients with Head and Neck Tumours, Caries
Research, 2011; 45(2): 136–141.
[4] Chavez JA, Adkinson CD, Adjunctive hyperbaric
oxygen in irradiated patients requiring dental
extractions: outcomes and complications, Journal of
Oral and Maxillofacial Surgery, 2001; 59(5): 518–522.
[5] PRISMA. https://prisma-statement.org//PRISMA
Statement/ FlowDiagram. Accessed 28 June 2022.
[6] Beech N, Robinson S, Porceddu S et al., Dental
management of patients irradiated for head and neck
cancer, Australian Dental Journal, 2014; 59(1): 20–28.
[7] Fakhry C, Improved survival of patients with human
papillomavirus-positive head and neck squamous cell
carcinoma in a prospective clinical trial, Journal of the
National Cancer Institute, 2008; 100(4): 261–269.
[8] Agrawal N, Exome sequencing of head and neck
squamous cell carcinoma reveals inactivating
mutations in NOTCH1, Science, 2011; 333(6046):
1154–1157.
[9] D’Souza G, Case-control study of human papillomavirus
and oropharyngeal cancer, The New England Journal of
Medicine, 2007; 356(19): 1944–1956.
[10] Halyard MY, Does zinc sulfate prevent therapy-induced
taste alterations in head and neck cancer patients?
Results of phase III double-blind, placebo-controlled
trial from the North Central Cancer Treatment Group
(N01C4), International Journal of Radiation Oncology,
Biology, Physics, 2007; vol. 67(5): 1318–1322.